Moderna 2022 Priorities and Capital Allocation slide image

Moderna 2022 Priorities and Capital Allocation

Today's Agenda 1 Business Review - Stéphane Bancel, CEO 2 1Q22 Earnings Call 3 Slide 35 SpikevaxⓇ COVID-19 Vaccine Update - Paul Burton, M.D., Ph.D., CMO Clinical Program Review – Stephen Hoge, M.D., President 4 Financials - David Meline, CFO 5 Looking Forward - Stéphane Bancel, CEO moderna
View entire presentation